Health Encyclopedia

Home | List of Topics | Cancer | Gynecologic Cancer

Arrhenoblastoma of ovary

Definition

Arrhenoblastoma of the ovary is an ovarian tumor that secretes testosterone.

Alternative Names

Stromal tumor; Gonadal stromal tumor; Sex cord tumor; Androblastoma

Causes, incidence, and risk factors

This is a rare tumor that accounts for less than 0.5% of all ovarian tumors. These tumors are found in women of all age groups, but are most common in young women.

Symptoms

This tumor secretes male hormones, which causes secondary sex changes in women including:

• Deepening of the voice
• Increased facial and body hair
• Increased size of the clitoris
• Male pattern baldness

Signs and tests

• Ultrasound of the ovaries
• CT scan of pelvis and abdomen to look for tumor spread
• Blood tests to check levels of hormones that may be secreted by the tumor

Treatment

Surgery is the main treatment. If the cancer has spread, chemotherapy or radiation therapy should be considered.

Support Groups

The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group.

Expectations (prognosis)

The outcome of this disease depends on its extent, and the ability to completely remove the tumor with surgery. The overall 5-year survival rate is 70 - 90%.

Fortunately, arrhenoblastoma has a low chance of spreading. If the tumor is detected early, the cure rate can be very good.

Complications

• Masculinization as described above.
• Surgical complications depending on the extent of surgery.
• Spread of the tumor if it is not completely removed.

Calling your health care provider

Call your health care provider if you are a woman experiencing signs of masculinization or if you feel a mass near your ovaries.

Prevention

There is no good screening test. Annual gynecological exams and early recognition of signs of masculinization are important in the detection of the disease.

Review Date:5/22/2006
Reviewed By:Adam S. Levy, MD, Director, Fellowship Training Program, Section of Pediatric Hematology/Oncology, The Children's Hospital at Montefiore, Bronx,NY. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.